'Live' imaging reveals breast cancer cells' transition to metastasis

December 06, 2009

The spread, or metastasis, of individual breast cancer cells from the main tumor into the blood circulation to the lungs and other body tissues and organs is under the control of a growth factor abbreviated TGFb, according to a study with laboratory mice that will be presented at the American Society for Cell Biology (ASCB) 49th Annual Meeting, Dec. 5-9, 2009 in San Diego.

These messenger genes may be a promising target for drugs to block the metastatic breast cancer route, said Erik Sahai, Ph.D., of Cancer Research UK in London.

"The results helped us to find the set of genes that are behind the spread of breast cancer -- and that the genes need to be first turned on and then off in order for single cancer cells to be able to 'relocate,'" Sahai said.

Sahai's presentation at the ASCB conference follows the Oct. 2009 publication of the study in Nature Cell Biology.

In their studies with laboratory mice with breast cancer, Sahai and his colleagues determined that the control switch is the TGFb (transforming growth factor beta) that previous research had shown to regulate normal cell growth and movement.

Using an advanced microscopy and analysis technique, the Cancer UK scientists documented the movement of the cancer cells from the mouse's primary tumor site.

Because the cancer cells were tagged with a "reporter" protein that glowed blue when the TGFb cell messenger system was active, the researchers were able to determine that single breast cancer cells broke away from the main tumor and entered the blood system when TGFb first turned on the messenger genes in the cancer cells and then turned them off.

But, when TGFb was inactive, clumps, not individual, breast cancer cells broke away from the main tumor. Because these clumps can spread only through the lymphatic system, the metastasis was local, not through the blood.

The spread of individual cancer cells is more life-threatening than is the metastasis of a group of cells.

While single cells can travel through the blood circulation to sites throughout the body, groups of cancer cells are limited the lymphatic system, which keeps them local.

Advanced microscopy and analysis, said Sahai, allows researchers to investigate cell signaling "live" while observing individual cancer cells make the crucial transition to metastasis. It gives science a closer look at a process that has been largely hidden.

"Surprisingly little is known about the way cancer cells spread through the body because it is so incredibly difficult to study," said Sahai.

"In a medium-sized tumor there could be a billion cells -- and only a small proportion might break away and spread. So it is like trying to find -- and understand -- a moving needle in a very big haystack."
-end-
Erik Sahai, Ph.D. (erik.sahai@cancer.org.uk; 011 44 20 72693165) will present "Imaging the metastatic process" at Sunday, Dec. 6, 8:35 to 8:55 a.m., Minisymposium 1 Cancer Cells, Program #2, Ballroom 20A.

American Society for Cell Biology

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.